Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects

NCT02886884 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: 20 million Allogeneic Mesenchymal Human Stem Cells
DRUG: 100 million Allogeneic Mesenchymal Human Stem Cells

Sponsor

Joshua M Hare

Collaborators

[object Object]